Cargando…

Renin angiotensin system inhibitors for patients with stable coronary artery disease without heart failure: systematic review and meta-analysis of randomized trials

Objective To critically evaluate the efficacy of renin angiotensin system inhibitors (RASi) in patients with coronary artery disease without heart failure, compared with active controls or placebo. Design Meta-analysis of randomized trials. Data sources PubMed, EMBASE, and CENTRAL databases until 1...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bangalore, Sripal, Fakheri, Robert, Wandel, Simon, Toklu, Bora, Wandel, Jasmin, Messerli, Franz H
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group Ltd. 2017
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5244819/ https://www.ncbi.nlm.nih.gov/pubmed/28104622 http://dx.doi.org/10.1136/bmj.j4

Ejemplares similares

Diabetes mellitus as a compelling indication for use of renin angiotensin system blockers: systematic review and meta-analysis of randomized trials
por: Bangalore, Sripal, et al.
Publicado: (2016)

Efficacy and safety of dual blockade of the renin-angiotensin system: meta-analysis of randomised trials
por: Makani, Harikrishna, et al.
Publicado: (2013)

Angiotensin receptor blockers and risk of myocardial infarction: meta-analyses and trial sequential analyses of 147 020 patients from randomised trials
por: Bangalore, Sripal, et al.
Publicado: (2011)

Bare metal stents, durable polymer drug eluting stents, and biodegradable polymer drug eluting stents for coronary artery disease: mixed treatment comparison meta-analysis
por: Bangalore, Sripal, et al.
Publicado: (2013)

Anticoagulant therapy during primary percutaneous coronary intervention for acute myocardial infarction: a meta-analysis of randomized trials in the era of stents and P2Y(12) inhibitors
por: Bangalore, Sripal, et al.
Publicado: (2014)

Efficacy of cilostazol on platelet reactivity and cardiovascular outcomes in patients undergoing percutaneous coronary intervention: insights from a meta-analysis of randomised trials
por: Bangalore, Sripal, et al.
Publicado: (2014)

Renin–Angiotensin–Aldosterone System Inhibitors and Risk of Covid-19
por: Reynolds, Harmony R., et al.
Publicado: (2020)

Renin-angiotensin-aldosterone system and kidney interactions in heart failure
por: Ferreira, João Pedro, et al.
Publicado: (2019)

The renin–angiotensin–aldosterone-system and right heart failure in congenital heart disease
por: Andersen, Stine, et al.
Publicado: (2016)

Brain Renin–Angiotensin System in Hypertension, Cardiac Hypertrophy, and Heart Failure
por: Campos, Luciana Aparecida, et al.
Publicado: (2012)

COVID-19 Interference with Renin-Angiotensin System in the Context of Heart Failure
por: Siniorakis, Eftychios, et al.
Publicado: (2020)

Gene Polymorphisms of the Renin-Angiotensin-Aldosterone System as Risk Factors for the Development of In-Stent Restenosis in Patients with Stable Coronary Artery Disease
por: Azova, Madina, et al.
Publicado: (2021)

Revascularization and survival in multivessel coronary artery disease in ischemia
por: Maron, David J., et al.
Publicado: (2022)

Role of the renin–angiotensin system in the pathophysiology of coronary heart disease and heart failure: Diagnostic biomarkers and therapy with drugs and natural products
por: Mehta, Jinit K., et al.
Publicado: (2023)

The State of Coronary Thrombus Aspiration
por: Pruthi, Sonal, et al.
Publicado: (2022)

The Genetic Variants in the Renin-Angiotensin System and the Risk of Heart Failure in Polish Patients
por: Gorący, Iwona, et al.
Publicado: (2022)

Renin–angiotensin system gene polymorphisms among Saudi patients with coronary artery disease
por: Al-Hazzani, Amal, et al.
Publicado: (2014)

Renin-Angiotensin Activation and Oxidative Stress in Early Heart Failure with Preserved Ejection Fraction
por: Negi, Smita I., et al.
Publicado: (2015)

Role of renin–angiotensin–aldosterone system inhibitors in heart failure and chronic kidney disease
por: Singhania, Namrata, et al.
Publicado: (2020)

Anaemia in Heart Failure Patients, Associated with Angiotensin – Renin – Aldosterone System Altering Medications
por: Jonaitienė, Neda, et al.
Publicado: (2021)

Renin-Angiotensin-Aldosterone System Activation and Diuretic Response in Ambulatory Patients With Heart Failure
por: Amatruda, Jonathan G., et al.
Publicado: (2022)

The effect of taurine supplementation on the renin–angiotensin–aldosterone system of dogs with congestive heart failure
por: Brethel, Sara, et al.
Publicado: (2023)

Renin-angiotensin system at the heart of COVID-19 pandemic
por: Alifano, Marco, et al.
Publicado: (2020)

Risk Assessment Using the Association Between Renin-Angiotensin Genes Polymorphisms and Coronary Artery Disease
por: Riad, Mohamed, et al.
Publicado: (2021)

Habitability and sub glacial liquid water on planets of M-dwarf stars
por: Wandel, Amri
Publicado: (2023)

Novel Therapeutic Approaches Targeting the Renin-Angiotensin System and Associated Peptides in Hypertension and Heart Failure
por: Arendse, Lauren B., et al.
Publicado: (2019)

Implications of renin‐angiotensin‐system blocker discontinuation in acute decompensated heart failure with systolic dysfunction
por: Darden, Douglas, et al.
Publicado: (2019)

Risk–Benefit Balance of Renin–Angiotensin–Aldosterone Inhibitor Cessation in Heart Failure Patients with Hyperkalemia
por: Kohsaka, Shun, et al.
Publicado: (2022)

Invasive Management of Coronary Artery Disease in Advanced Renal Disease
por: Karimi Galougahi, Keyvan, et al.
Publicado: (2021)

Circulating plasma concentrations of angiotensin-converting enzyme 2 in men and women with heart failure and effects of renin–angiotensin–aldosterone inhibitors
por: Sama, Iziah E, et al.
Publicado: (2020)

What’s new in the renin-angiotensin system?: What’s new in the renin-angiotensin system?
por: Smith, A. I., et al.
Publicado: (2004)

Impact of Renin‐Angiotensin System Inhibitors on Long‐Term Clinical Outcomes of Patients With Coronary Artery Spasm
por: Choi, Byoung Geol, et al.
Publicado: (2016)

Effects of Exercise Training on Circulating and Skeletal Muscle Renin-Angiotensin System in Chronic Heart Failure Rats
por: Gomes-Santos, Igor Lucas, et al.
Publicado: (2014)

Renin–angiotensin blockade in heart failure with preserved ejection fraction: a systematic review and meta‐analysis
por: Khan, Muhammad Shahzeb, et al.
Publicado: (2017)

Effects of neprilysin-renin inhibition in comparison with neprilysin-angiotensin inhibition on the neurohumoral changes in rats with heart failure
por: Dizaye, Kawa, et al.
Publicado: (2019)

Use of Renin–Angiotensin–Aldosterone System Inhibitors in Older Patients with Heart Failure and Reduced Ejection Fraction
por: Stolfo, Davide, et al.
Publicado: (2019)

Reply to Siniorakis et al., “COVID-19 Interference with Renin-Angiotensin System in the Context of Heart Failure”
por: Fedson, David S., et al.
Publicado: (2020)

Hyperkalemia and Renin–Angiotensin–Aldosterone System Inhibitors Dose Therapy in Heart Failure With Reduced Ejection Fraction
por: Rosano, Giuseppe MC, et al.
Publicado: (2019)

International Summer Course in Plasma Physics 1960
por: Wandel, C F
Publicado: (1960)

Prognostic Impacts of Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers in Acute Coronary Syndrome Patients Without Heart Failure
por: Chen, Runzhen, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_mu5nb33c7ildi8u08rnmg8hibd